Cargando…

Cardiovascular risk evaluation through heart rate variability analysis in psoriatic patients before and after 24 weeks of etanercept therapy: Prospective study

OBJECTIVE: To assess the influence of etanercept, an anti-tumour necrosis factor (TNF)-α agent, on autonomic cardiovascular regulation in young patients with moderate-to-severe psoriasis without cardiovascular risk factors. METHODS: Patients with psoriasis underwent 5-min electrocardiogram (ECG) rec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Potenza, Concetta, Raimondi, Gianfranco, Pampena, Riccardo, Proietti, Ilaria, Viola, Giorgio La, Bernardini, Nicoletta, Tolino, Ersilia, Zuber, Sara, Balduzzi, Veronica, Scordamaglia, Beatrice, Skroza, Nevena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2016
Materias:	Immuno-Mediated Diseases and Treatment Immunogenicity
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536535/ https://www.ncbi.nlm.nih.gov/pubmed/27683138 http://dx.doi.org/10.1177/0300060515593242

Ejemplares similares

Long-term treatment with adalimumab in psoriatic arthritis: serum adalimumab concentration, immunogenicity and the link with clinical response
por: Chimenti, Maria Sole, et al.
Publicado: (2016)

How the immune system responds to therapeutic biological agents
por: Vultaggio, Alessandra, et al.
Publicado: (2016)

Serological markers associated with disease activity in patients with rheumatoid arthritis treated with rituximab
por: Conigliaro, Paola, et al.
Publicado: (2016)

Correlations between Psoriasis and Inflammatory Bowel Diseases
por: Skroza, Nevena, et al.
Publicado: (2013)

Treatment of psoriasis with etanercept in immunocompromised patients: Two case reports
por: De Simone, Clara, et al.
Publicado: (2016)

Management of psoriatic patients in biologic treatment associated with infectious comorbidities
por: Nicoletta, Bernardini, et al.
Publicado: (2020)

Long-term safety of etanercept in psoriasis: Retrospective study focused on infections
por: Orsini, Diego, et al.
Publicado: (2016)

A Review of the Literature of Surgical and Nonsurgical Treatments of Invasive Squamous Cells Carcinoma
por: Potenza, Concetta, et al.
Publicado: (2018)

Influence of body mass index and weight on etanercept efficacy in patients with psoriasis: A retrospective study
por: Giunta, Alessandro, et al.
Publicado: (2016)

Factors influencing response to ingenol mebutate therapy for actinic keratosis of face and scalp
por: Skroza, Nevena, et al.
Publicado: (2017)

Safety and Impact of Anti-COVID-19 Vaccines in Psoriatic Patients Treated with Biologics: A Real Life Experience
por: Skroza, Nevena, et al.
Publicado: (2021)

Efficacy of Cemiplimab in a Patient Affected by Cutaneous Squamous Cell Carcinoma and Myelodysplastic Syndrome
por: Proietti, Ilaria, et al.
Publicado: (2023)

Evaluation of Cardiovascular Risk in Hidradenitis Suppurativa Patients Using Heart Rate Variability (HRV) Analysis
por: Skroza, Nevena, et al.
Publicado: (2020)

The Role of the Western Diet on Atopic Dermatitis: Our Experience and Review of the Current Literature
por: Ilaria, Proietti, et al.
Publicado: (2023)

A Case of Psoriatic Disease and Hidradenitis Suppurativa in a Child with Chromosome 17q21.31 Microduplication Syndrome
por: Tolino, Ersilia, et al.
Publicado: (2023)

IL‐17 and its role in inflammatory, autoimmune, and oncological skin diseases: state of art
por: Bernardini, Nicoletta, et al.
Publicado: (2019)

Advantages of Tailored Isotretinoin Treatment in Moderate to Severe Acne: Real-Life Data
por: Skroza, Nevena, et al.
Publicado: (2021)

A case of twins affected by psoriasis, psoriatic arthritis and autism: Five years of efficacious and safe treatment with Secukinumab
por: Bernardini, Nicoletta, et al.
Publicado: (2022)

Do Diet and Lifestyles Play a Role in the Pathogenesis of NMSCs?
por: Skroza, Nevena, et al.
Publicado: (2020)

Eruptive Blue Nevi of the Scalp in a Patient with Mayer–Rokitansky–Küster–Hauser Syndrome during Isotretinoin Therapy
por: Skroza, Nevena, et al.
Publicado: (2019)

Aesthetic Treatments in Cancer Patients
por: Proietti, Ilaria, et al.
Publicado: (2021)

Mechanisms of Acquired BRAF Inhibitor Resistance in Melanoma: A Systematic Review
por: Proietti, Ilaria, et al.
Publicado: (2020)

Suicide risk and psychiatric comorbidity in patients with psoriasis
por: Pompili, Maurizio, et al.
Publicado: (2016)

Clinical utility of ingenol mebutate in the management of actinic keratosis: perspectives from clinical practice
por: Skroza, Nevena, et al.
Publicado: (2018)

BRAF Inhibitors: Molecular Targeting and Immunomodulatory Actions
por: Proietti, Ilaria, et al.
Publicado: (2020)

Guselkumab for the treatment of severe plaque psoriasis in a schizophrenia patient
por: Bernardini, Nicoletta, et al.
Publicado: (2022)

Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema
por: Bernardini, Nicoletta, et al.
Publicado: (2022)

Long-Term Maintained Response to Selective Internal Radiation Therapy in an Oligometastatic Uveal Melanoma Patient Treated with Concomitant Anti-PD-1 Therapy
por: Proietti, Ilaria, et al.
Publicado: (2021)

Supraorbital Basosquamous Carcinoma Treated with Cemiplimab Followed by Sonidegib: A Case Report and Review of the Literature
por: Proietti, Ilaria, et al.
Publicado: (2023)

How lockdown measures, during COVID-19 pandemic, matter on psoriatic patient’s perception: Study on 600 patients on biologic therapy
por: Bernardini, N., et al.
Publicado: (2021)

Beneficial effects of long-term treatment with bosentan on the development of pulmonary arterial hypertension in patients with systemic sclerosis
por: Murdaca, Giuseppe, et al.
Publicado: (2016)

Post-translational modifications in rheumatoid arthritis and atherosclerosis: Focus on citrullination and carbamylation
por: Spinelli, Francesca Romana, et al.
Publicado: (2016)

Asymmetric dimethylarginine and arterial stiffness in patients with rheumatoid arthritis: A case–control study
por: Erre, Gian Luca, et al.
Publicado: (2016)

Adverse skin reactions to personal protective equipment during COVID‐19 pandemic in Italian health care workers
por: Proietti, Ilaria, et al.
Publicado: (2022)

Ongoing Phase I Studies of Immune Checkpoint Inhibitors in China
por: Fang, Wenfeng, et al.
Publicado: (2019)

Immune‐Related Adverse Events by Immune Checkpoint Inhibitors Significantly Predict Durable Efficacy Even in Responders with Advanced Non‐Small Cell Lung Cancer
por: Akamatsu, Hiroaki, et al.
Publicado: (2019)

Combined Effect of Sarcopenia and Systemic Inflammation on Survival in Patients with Advanced Stage Cancer Treated with Immunotherapy
por: Bilen, Mehmet Asim, et al.
Publicado: (2019)

PD‐L1 Expression on Circulating Tumor Cells May Be Predictive of Response to Pembrolizumab in Advanced Melanoma: Results from a Pilot Study
por: Khattak, Muhammad A., et al.
Publicado: (2019)

Systematic Review of PD‐1/PD‐L1 Inhibitors in Oncology: From Personalized Medicine to Public Health
por: Chang, Elaine, et al.
Publicado: (2021)

The Inconsistent and Inadequate Reporting Of Immune‐Related Adverse Events in PD‐1/PD‐L1 Inhibitors: A Systematic Review of Randomized Controlled Clinical Trials
por: Xie, Tong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ffp7povb01ekto98av3rbbdb51